Unconfigured Ad
Collapse
SEQanswers sponsors/vendors can post commercial content here with approval from admin. Please support our sponsors!
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by Bruker, 04-07-2025, 06:25 AM
|
3 responses
451 views
0 reactions
|
Last Post
by pekgio
06-07-2026, 10:46 PM
|
||
|
NGRL combines CTC analysis with cfDNA strategies to transform cancer detection and monitoring
by Bio-Rad Laboratories
Started by Bio-Rad Laboratories, 12-04-2025, 02:57 PM
|
2 responses
177 views
0 reactions
|
Last Post
by verity
04-16-2026, 10:34 PM
|
||
|
Started by PerkinElmer AG, 07-25-2019, 07:55 AM
|
1 response
8,159 views
0 reactions
|
Last Post
by cement_head
02-09-2026, 12:22 PM
|
||
|
Started by Bruker, 06-23-2025, 08:07 AM
|
1 response
649 views
0 reactions
|
Last Post
by David hoff
07-16-2025, 03:14 AM
|
||
|
Started by seqadmin, 12-10-2024, 08:04 AM
|
0 responses
181 views
0 reactions
|
Last Post
by seqadmin
12-10-2024, 08:04 AM
|
||
|
Started by seqadmin, 11-27-2024, 02:41 PM
|
0 responses
173 views
0 reactions
|
Last Post
by seqadmin
11-27-2024, 02:41 PM
|
||
|
Started by Novogene, 11-21-2024, 02:02 PM
|
0 responses
466 views
0 reactions
|
Last Post
by Novogene
11-21-2024, 02:02 PM
|
||
|
Started by Novogene, 11-01-2024, 10:13 AM
|
0 responses
252 views
0 reactions
|
Last Post
by Novogene
11-01-2024, 10:13 AM
|
||
|
Exploring the Power of Whole Genome Sequencing: A Beginner’s Guide to Long-read Sequencing
by Novogene
Started by Novogene, 10-21-2024, 05:49 PM
|
0 responses
360 views
0 reactions
|
Last Post
by Novogene
10-21-2024, 05:49 PM
|
||
|
Started by Novogene, 09-16-2024, 07:51 AM
|
0 responses
392 views
0 reactions
|
Last Post
by Novogene
09-16-2024, 07:51 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
Today, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
Today, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 02:55 AM
|
0 responses
7 views
0 reactions
|
Last Post
by SEQadmin2
Today, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|